HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis

NYSE:HIMS • US4330001060

15.63 USD
-0.19 (-1.2%)
At close: Feb 20, 2026
15.799 USD
+0.17 (+1.08%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HIMS. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HIMS was profitable.
  • In the past year HIMS had a positive cash flow from operations.
  • HIMS had negative earnings in 4 of the past 5 years.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • HIMS has a Return On Assets of 5.99%. This is amongst the best in the industry. HIMS outperforms 81.37% of its industry peers.
  • With an excellent Return On Equity value of 23.03%, HIMS belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
  • HIMS has a better Return On Invested Capital (5.84%) than 62.75% of its industry peers.
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROIC 5.84%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

  • The Profit Margin of HIMS (6.05%) is better than 81.37% of its industry peers.
  • With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 67.65% of the companies in the same industry.
  • HIMS's Gross Margin of 75.01% is amongst the best of the industry. HIMS outperforms 90.20% of its industry peers.
  • In the last couple of years the Gross Margin of HIMS has grown nicely.
Industry RankSector Rank
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
  • The number of shares outstanding for HIMS has been increased compared to 1 year ago.
  • The number of shares outstanding for HIMS has been increased compared to 5 years ago.
  • There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.62 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HIMS has a Altman-Z score (2.62) which is in line with its industry peers.
  • HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
  • HIMS has a Debt to FCF ratio of 8.13. This is comparable to the rest of the industry: HIMS outperforms 50.98% of its industry peers.
  • A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
  • HIMS's Debt to Equity ratio of 1.67 is on the low side compared to the rest of the industry. HIMS is outperformed by 69.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Altman-Z 2.62
ROIC/WACC0.67
WACC8.72%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 77.45% of its industry peers.
  • HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • HIMS has a better Quick ratio (1.64) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.64
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
  • The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
  • Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 78.02%.
  • HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.57% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 22.80% on average per year.
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.94, the valuation of HIMS can be described as expensive.
  • HIMS's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, HIMS is valued at the same level.
  • HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 26.88.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. HIMS is around the same levels.
Industry RankSector Rank
PE 28.94
Fwd PE 26.88
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
Industry RankSector Rank
P/FCF 29.78
EV/EBITDA 20.99
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • HIMS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as HIMS's earnings are expected to grow with 13.74% in the coming years.
PEG (NY)N/A
PEG (5Y)0.48
EPS Next 2Y3.76%
EPS Next 3Y13.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HIMS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS & HERS HEALTH INC

NYSE:HIMS (2/20/2026, 8:04:00 PM)

After market: 15.799 +0.17 (+1.08%)

15.63

-0.19 (-1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners94.2%
Inst Owner Change-5.43%
Ins Owners5.93%
Ins Owner Change-1.41%
Market Cap3.56B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.27
Price Target43.45 (177.99%)
Short Float %37.45%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.36%
PT rev (3m)-12.76%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-50.63%
EPS NY rev (1m)1.4%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 28.94
Fwd PE 26.88
P/S 1.61
P/FCF 29.78
P/OCF 10.95
P/B 6.12
P/tB 28.06
EV/EBITDA 20.99
EPS(TTM)0.54
EY3.45%
EPS(NY)0.58
Fwd EY3.72%
FCF(TTM)0.52
FCFY3.36%
OCF(TTM)1.43
OCFY9.14%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.48
Graham Number5.57
Profitability
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROCE 7.39%
ROIC 5.84%
ROICexc 9.03%
ROICexgc 14.91%
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
FCFM 5.4%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Debt/EBITDA 5.57
Cap/Depr 484.08%
Cap/Sales 9.3%
Interest Coverage 250
Cash Conversion 186.53%
Profit Quality 89.31%
Current Ratio 1.88
Quick Ratio 1.64
Altman-Z 2.62
F-Score3
WACC8.72%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.58%
EBIT Next 3Y89.54%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


What is the profitability of HIMS stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.


What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.